Clinical Trial Update: Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

The Phase 2 trial investigating the creation of a bone marrow microenvironment to treat myelodysplastic syndromes in conjunction with allogeneic stem cell trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myelofibrosis

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Myelodysplastic Syndromes, Myelofibrosis | Phase 2 | Status: WITHDRAWN